155 related articles for article (PubMed ID: 10813146)
21. Risk of empyema in patients with chronic liver disease and cirrhosis: A nationwide, population-based cohort study.
Shen TC; Chen CH; Lai HC; Lin CL; Tu CY; Hsia TC; Shih CM; Hsu WH; Sung FC
Liver Int; 2017 Jun; 37(6):862-870. PubMed ID: 27896931
[TBL] [Abstract][Full Text] [Related]
22. Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992.
Lillebaek T; Poulsen S; Kok-Jensen A
Int J Tuberc Lung Dis; 1999 Jul; 3(7):603-12. PubMed ID: 10423223
[TBL] [Abstract][Full Text] [Related]
23. Risk of acute coronary syndrome and peripheral arterial disease in chronic liver disease and cirrhosis: A nationwide population-based study.
Lin SY; Lin CL; Lin CC; Wang IK; Hsu WH; Kao CH
Atherosclerosis; 2018 Mar; 270():154-159. PubMed ID: 29425961
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a comorbidity scoring system for patients with cirrhosis.
Jepsen P; Vilstrup H; Lash TL
Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
[TBL] [Abstract][Full Text] [Related]
25. Thirty-day postoperative mortality after hysterectomy in women with liver cirrhosis: a Danish population-based cohort study.
Nielsen IL; Thulstrup AM; Nielsen GL; Larsen H; Vilstrup H; Sørensen HT
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):202-5. PubMed ID: 11950492
[TBL] [Abstract][Full Text] [Related]
26. Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study.
Sørensen HT; Mellemkjaer L; Jepsen P; Thulstrup AM; Baron J; Olsen JH; Vilstrup H
J Clin Gastroenterol; 2003 Apr; 36(4):356-9. PubMed ID: 12642745
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N
J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141
[TBL] [Abstract][Full Text] [Related]
28. Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study.
Nielsen LH; Jensen-Fangel S; Benfield T; Skov R; Jespersen B; Larsen AR; Østergaard L; Støvring H; Schønheyder HC; Søgaard OS
BMC Infect Dis; 2015 Jan; 15():6. PubMed ID: 25566857
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study.
Grønbæk L; Vilstrup H; Jepsen P
J Hepatol; 2014 Mar; 60(3):612-7. PubMed ID: 24326217
[TBL] [Abstract][Full Text] [Related]
30. Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients.
Henrion J; Libon E; De Maeght S; Schapira M; Ghilain JM; Maisin JM; Heller FR
Acta Gastroenterol Belg; 2000; 63(1):5-9. PubMed ID: 10907311
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma.
Yoneyama K; Miyagishi K; Kiuchi Y; Shibata M; Mitamura K
J Gastroenterol; 2002; 37(12):1028-34. PubMed ID: 12522534
[TBL] [Abstract][Full Text] [Related]
32. Effect of liver cirrhosis on metastasis in colorectal cancer patients: a nationwide population-based cohort study.
Chiou WY; Chang CM; Tseng KC; Hung SK; Lin HY; Chen YC; Su YC; Tseng CW; Tsai SJ; Lee MS; Li CY
Jpn J Clin Oncol; 2015 Feb; 45(2):160-8. PubMed ID: 25378650
[TBL] [Abstract][Full Text] [Related]
33. The incidence and prognosis of patients with bacteremia.
Nielsen SL
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183054
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, incidence, and autoimmune comorbidities of celiac disease: a nation-wide, population-based study in Denmark from 1977 to 2016.
Grode L; Bech BH; Jensen TM; Humaidan P; Agerholm IE; Plana-Ripoll O; Ramlau-Hansen CH
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):83-91. PubMed ID: 29076940
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand.
Hsiang JC; Bai WW; Raos Z; Stableforth W; Upton A; Selvaratnam S; Gane EJ; Gerred SJ
Intern Med J; 2015 Feb; 45(2):160-9. PubMed ID: 25371019
[TBL] [Abstract][Full Text] [Related]
36. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis.
Gonzalez OY; Adams G; Teeter LD; Bui TT; Musser JM; Graviss EA
Int J Tuberc Lung Dis; 2003 Dec; 7(12):1178-85. PubMed ID: 14677893
[TBL] [Abstract][Full Text] [Related]
37. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
Chu CM; Liaw YF
Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
[TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic cirrhosis and the risk of stroke: a 5-year follow-up study.
Chen YH; Chen KY; Lin HC
Liver Int; 2011 Mar; 31(3):354-60. PubMed ID: 20860634
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of alcoholic liver disease in Denmark 2006-2011: a population-based study.
Deleuran T; Vilstrup H; Becker U; Jepsen P
Alcohol Alcohol; 2015 May; 50(3):352-7. PubMed ID: 25681463
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and natural history of Wilson's disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016.
Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
World J Gastroenterol; 2017 Nov; 23(43):7716-7726. PubMed ID: 29209112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
